Report Detail
Global (United States, European Union and China) Therapeutic Nuclear Medicines Market Research Report 2019-2025
- RnM3351974 |
- 24 April, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
In 2019, the market size of Therapeutic Nuclear Medicines is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Therapeutic Nuclear Medicines.
This report studies the global market size of Therapeutic Nuclear Medicines, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Therapeutic Nuclear Medicines sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Cardinal Health
Mallinckrodt
GE Healthcare
Lantheus Medical Imaging
Bayer
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications
IBA Molecular Imaging
Market Segment by Product Type
Beta Emitters
Alpha Emitters
Brachytherapy Products
Market Segment by Application
Thyroid
Bone Metastasis
Lymphoma
Endocrine Tumors
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Therapeutic Nuclear Medicines status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Therapeutic Nuclear Medicines manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Therapeutic Nuclear Medicines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Beta Emitters
- 1.3.3 Alpha Emitters
- 1.3.4 Brachytherapy Products
- 1.4 Market Segment by Application
- 1.4.1 Global Therapeutic Nuclear Medicines Market Share by Application (2019-2025)
- 1.4.2 Thyroid
- 1.4.3 Bone Metastasis
- 1.4.4 Lymphoma
- 1.4.5 Endocrine Tumors
- 1.4.6 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Therapeutic Nuclear Medicines Market Size
- 2.1.1 Global Therapeutic Nuclear Medicines Revenue 2014-2025
- 2.1.2 Global Therapeutic Nuclear Medicines Sales 2014-2025
- 2.2 Therapeutic Nuclear Medicines Growth Rate by Regions
- 2.2.1 Global Therapeutic Nuclear Medicines Sales by Regions 2014-2019
- 2.2.2 Global Therapeutic Nuclear Medicines Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Therapeutic Nuclear Medicines Sales by Manufacturers
- 3.1.1 Therapeutic Nuclear Medicines Sales by Manufacturers 2014-2019
- 3.1.2 Therapeutic Nuclear Medicines Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Therapeutic Nuclear Medicines Revenue by Manufacturers (2014-2019)
- 3.2.2 Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Therapeutic Nuclear Medicines Market Concentration Ratio (CR5 and HHI)
- 3.3 Therapeutic Nuclear Medicines Price by Manufacturers
- 3.4 Key Manufacturers Therapeutic Nuclear Medicines Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Therapeutic Nuclear Medicines Market
- 3.6 Key Manufacturers Therapeutic Nuclear Medicines Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Beta Emitters Sales and Revenue (2014-2019)
- 4.1.2 Alpha Emitters Sales and Revenue (2014-2019)
- 4.1.3 Brachytherapy Products Sales and Revenue (2014-2019)
- 4.2 Global Therapeutic Nuclear Medicines Sales Market Share by Type
- 4.3 Global Therapeutic Nuclear Medicines Revenue Market Share by Type
- 4.4 Therapeutic Nuclear Medicines Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Therapeutic Nuclear Medicines Sales by Application
6 United States
- 6.1 United States Therapeutic Nuclear Medicines Breakdown Data by Company
- 6.2 United States Therapeutic Nuclear Medicines Breakdown Data by Type
- 6.3 United States Therapeutic Nuclear Medicines Breakdown Data by Application
7 European Union
- 7.1 European Union Therapeutic Nuclear Medicines Breakdown Data by Company
- 7.2 European Union Therapeutic Nuclear Medicines Breakdown Data by Type
- 7.3 European Union Therapeutic Nuclear Medicines Breakdown Data by Application
8 China
- 8.1 China Therapeutic Nuclear Medicines Breakdown Data by Company
- 8.2 China Therapeutic Nuclear Medicines Breakdown Data by Type
- 8.3 China Therapeutic Nuclear Medicines Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Therapeutic Nuclear Medicines Breakdown Data by Company
- 9.2 Rest of World Therapeutic Nuclear Medicines Breakdown Data by Type
- 9.3 Rest of World Therapeutic Nuclear Medicines Breakdown Data by Application
- 9.4 Rest of World Therapeutic Nuclear Medicines Breakdown Data by Countries
- 9.4.1 Rest of World Therapeutic Nuclear Medicines Sales by Countries
- 9.4.2 Rest of World Therapeutic Nuclear Medicines Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Cardinal Health
- 10.1.1 Cardinal Health Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Therapeutic Nuclear Medicines
- 10.1.4 Therapeutic Nuclear Medicines Product Introduction
- 10.1.5 Cardinal Health Recent Development
- 10.2 Mallinckrodt
- 10.2.1 Mallinckrodt Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Therapeutic Nuclear Medicines
- 10.2.4 Therapeutic Nuclear Medicines Product Introduction
- 10.2.5 Mallinckrodt Recent Development
- 10.3 GE Healthcare
- 10.3.1 GE Healthcare Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Therapeutic Nuclear Medicines
- 10.3.4 Therapeutic Nuclear Medicines Product Introduction
- 10.3.5 GE Healthcare Recent Development
- 10.4 Lantheus Medical Imaging
- 10.4.1 Lantheus Medical Imaging Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Therapeutic Nuclear Medicines
- 10.4.4 Therapeutic Nuclear Medicines Product Introduction
- 10.4.5 Lantheus Medical Imaging Recent Development
- 10.5 Bayer
- 10.5.1 Bayer Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Therapeutic Nuclear Medicines
- 10.5.4 Therapeutic Nuclear Medicines Product Introduction
- 10.5.5 Bayer Recent Development
- 10.6 Bracco Imaging
- 10.6.1 Bracco Imaging Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Therapeutic Nuclear Medicines
- 10.6.4 Therapeutic Nuclear Medicines Product Introduction
- 10.6.5 Bracco Imaging Recent Development
- 10.7 Eczacibasi-Monrol Nuclear Products
- 10.7.1 Eczacibasi-Monrol Nuclear Products Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Therapeutic Nuclear Medicines
- 10.7.4 Therapeutic Nuclear Medicines Product Introduction
- 10.7.5 Eczacibasi-Monrol Nuclear Products Recent Development
- 10.8 Nordion
- 10.8.1 Nordion Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Therapeutic Nuclear Medicines
- 10.8.4 Therapeutic Nuclear Medicines Product Introduction
- 10.8.5 Nordion Recent Development
- 10.9 Advanced Accelerator Applications
- 10.9.1 Advanced Accelerator Applications Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Therapeutic Nuclear Medicines
- 10.9.4 Therapeutic Nuclear Medicines Product Introduction
- 10.9.5 Advanced Accelerator Applications Recent Development
- 10.10 IBA Molecular Imaging
- 10.10.1 IBA Molecular Imaging Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Therapeutic Nuclear Medicines
- 10.10.4 Therapeutic Nuclear Medicines Product Introduction
- 10.10.5 IBA Molecular Imaging Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Therapeutic Nuclear Medicines Sales Channels
- 11.2.2 Therapeutic Nuclear Medicines Distributors
- 11.3 Therapeutic Nuclear Medicines Customers
12 Market Forecast
- 12.1 Global Therapeutic Nuclear Medicines Sales and Revenue Forecast 2019-2025
- 12.2 Global Therapeutic Nuclear Medicines Sales Forecast by Type
- 12.3 Global Therapeutic Nuclear Medicines Sales Forecast by Application
- 12.4 Therapeutic Nuclear Medicines Forecast by Regions
- 12.4.1 Global Therapeutic Nuclear Medicines Sales Forecast by Regions 2019-2025
- 12.4.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Therapeutic Nuclear Medicines . Industry analysis & Market Report on Therapeutic Nuclear Medicines is a syndicated market report, published as Global (United States, European Union and China) Therapeutic Nuclear Medicines Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Therapeutic Nuclear Medicines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
